Health Catalyst (NASDAQ:HCAT) and Jianpu Technology (NASDAQ:JT) Critical Contrast

Share on StockTwits

Health Catalyst (NASDAQ:HCAT) and Jianpu Technology (NYSE:JT) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Health Catalyst and Jianpu Technology, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Catalyst 0 0 9 1 3.10
Jianpu Technology 1 1 1 0 2.00

Health Catalyst presently has a consensus price target of $50.22, suggesting a potential upside of 62.11%. Jianpu Technology has a consensus price target of $9.50, suggesting a potential upside of 711.97%. Given Jianpu Technology’s higher possible upside, analysts clearly believe Jianpu Technology is more favorable than Health Catalyst.

Profitability

This table compares Health Catalyst and Jianpu Technology’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Health Catalyst N/A N/A N/A
Jianpu Technology -16.20% -21.83% -15.12%

Earnings & Valuation

This table compares Health Catalyst and Jianpu Technology’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Health Catalyst N/A N/A N/A N/A N/A
Jianpu Technology $292.61 million 0.68 -$23.94 million ($0.14) -8.36

Health Catalyst has higher earnings, but lower revenue than Jianpu Technology.

Insider and Institutional Ownership

45.9% of Health Catalyst shares are held by institutional investors. Comparatively, 18.4% of Jianpu Technology shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Health Catalyst beats Jianpu Technology on 7 of the 9 factors compared between the two stocks.

About Health Catalyst

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services. The company is headquartered in Salt Lake City, Utah.

About Jianpu Technology

Jianpu Technology Inc. operates a platform that provides online discovery and recommendation services for financial products in the People's Republic of China. Its platform allows users to access to financial products, including consumer and other loans, credit cards, and wealth management products. The company recommends loans and credit cards to individual users and assists the financial service providers in targeting users with specific characteristics based on the users' financial needs and credit profile, as well as the products offerings and risk appetite of the financial service providers. Its platform provides sales and marketing, big data risk management, and integrated solutions primarily to financial service providers. The company operates its platform under the Rong360 brand name. Jianpu Technology Inc. was founded in 2011 and is headquartered in Beijing, China.

Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Daniel J. Brennan Sells 20,463 Shares of Boston Scientific Co.  Stock
Daniel J. Brennan Sells 20,463 Shares of Boston Scientific Co. Stock
Insider Selling: Intuitive Surgical, Inc.  SVP Sells 1,492 Shares of Stock
Insider Selling: Intuitive Surgical, Inc. SVP Sells 1,492 Shares of Stock
Lynn Rothman Sells 5,000 Shares of Penumbra Inc  Stock
Lynn Rothman Sells 5,000 Shares of Penumbra Inc Stock
Insider Selling: ChemoCentryx Inc  Insider Sells 18,941 Shares of Stock
Insider Selling: ChemoCentryx Inc Insider Sells 18,941 Shares of Stock
Robert Fauber Sells 3,721 Shares of Moody’s Co.  Stock
Robert Fauber Sells 3,721 Shares of Moody’s Co. Stock
Insider Selling: Sunrun Inc  Chairman Sells 50,000 Shares of Stock
Insider Selling: Sunrun Inc Chairman Sells 50,000 Shares of Stock


 
© 2006-2020 Zolmax.